Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure

被引:67
作者
El-Armouche, A
Zolk, O
Rau, T
Eschenhagen, T
机构
[1] Univ Klinikum Hamburg Eppendorf, Inst Expt & Klin Pharmakol, D-20246 Hamburg, Germany
[2] Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, Erlangen, Germany
关键词
G-proteins; beta-adrenergic desensitization; heart failure; adenovirus; betablocker;
D O I
10.1016/j.cardiores.2003.09.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is accompanied by stereotypic alterations in cardiac gene expression. These changes are most likely secondary in the pathogenesis and can be viewed as protective, e.g. as energy-saving mechanisms, but at the same time, they aggravate contractile dysfunction and the deficit of failing cardiac myocytes to respond to altered hemodynamic needs. One of the best-studied, paradigmatic examples of this dichotomy is heterologous desensitization of the cardiac adenylyl cyclase (AC) signaling pathway. It protects against detrimental consequences of the excessive adrenergic drive, but it also blunts the most powerful inotropic support of the heart. Desensitization is associated with downregulation of beta-adrenergic receptors, increased beta-adrenoceptor kinases and increased inhibitory G protein alpha-subunits, G(alphai). Whereas a causative role of the former is generally accepted, the role of the increase in G(alphai) has remained controversial for many years. The present article summarizes early and novel findings that, in the view of the authors, provide solid evidence for G(alphai) to play an important role in the adaptation of cardiac AC to various pathophysiological conditions. (C) 2003 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
引用
收藏
页码:478 / 487
页数:10
相关论文
共 98 条
  • [1] Agonist-independent tonic inhibitory influence of G(i) on adenylate cyclase activity in rabbit ventricular myocardium and its removal by pertussis toxin: A role of empty receptor-mediated G(i) activation
    Akaishi, Y
    Hattori, Y
    Kanno, M
    Sakuma, I
    Kitabatake, A
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (02) : 765 - 775
  • [2] Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells:: role of AT1 receptors
    Anand-Srivastava, M
    Palaparti, A
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 150 - 158
  • [3] AnandSrivastava MB, 1996, MOL CELL BIOCHEM, V157, P163
  • [4] Inhibition of adenylyl cyclase isoforms V and VI by various Gβγ subunits
    Bayewitch, ML
    Avidor-Reiss, T
    Levy, R
    Pfeuffer, T
    Nevo, I
    Simonds, WF
    Vogel, Z
    [J]. FASEB JOURNAL, 1998, 12 (11) : 1019 - 1025
  • [5] BAYLISS J, 1987, BRIT HEART J, V57, P17
  • [6] Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction
    Benedict, CR
    Shelton, B
    Johnstone, DE
    Francis, G
    Greenberg, B
    Konstam, M
    Probstfield, JL
    Yusuf, S
    [J]. CIRCULATION, 1996, 94 (04) : 690 - 697
  • [7] BETHKE T, 1992, ARZNEIMITTEL-FORSCH, V42-1, P437
  • [8] INCREASE OF GI-ALPHA IN HUMAN HEARTS WITH DILATED BUT NOT ISCHEMIC CARDIOMYOPATHY
    BOHM, M
    GIERSCHIK, P
    JAKOBS, KH
    PIESKE, B
    SCHNABEL, P
    UNGERER, M
    ERDMANN, E
    [J]. CIRCULATION, 1990, 82 (04) : 1249 - 1265
  • [9] EVIDENCE FOR REDUCTION OF NOREPINEPHRINE UPTAKE SITES IN THE FAILING HUMAN HEART
    BOHM, M
    LAROSEE, K
    SCHWINGER, RHG
    ERDMANN, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (01) : 146 - 153
  • [10] RADIOIMMUNOCHEMICAL QUANTIFICATION OF GI-ALPHA IN RIGHT-AND-LEFT-VENTRICLES FROM PATIENTS WITH ISCHEMIC AND DILATED CARDIOMYOPATHY AND PREDOMINANT LEFT-VENTRICULAR FAILURE
    BOHM, M
    ESCHENHAGEN, T
    GIERSCHIK, P
    LARISCH, K
    LENSCHE, H
    MENDE, U
    SCHMITZ, W
    SCHNABEL, P
    SCHOLZ, H
    STEINFATH, M
    ERDMANN, E
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (02) : 133 - 149